Greece's Cannabis Paradox: Ancient Trade to Modern Skepticism

Photo by Daniel Nouri via Pexels.

Greece exported roughly 49 kilograms of medical cannabis to Germany in the first quarter of 2025 alone, has two major pharmaceutical cultivators running industrial-scale grow operations in Larissa and Examilia, and is being pitched by its own government as the Mediterranean's answer to Portugal for EU-compliant cannabis production. That same country, in the spring of 2026, banned the retail sale of hemp and CBD flower outright, sending inspectors from the national medicines agency to shut down shelves that had been legally stocked days earlier.

These two facts sit uncomfortably next to each other, but they're not really a contradiction -- they're a pattern, and it's an old one. Twenty-four hundred years before EOF inspectors started checking hemp shop inventories, Herodotus wrote about a foreign people who threw hemp seed onto hot stones and howled with pleasure in the vapor, and he described it the way a curious but slightly wary tourist describes something he finds impressive and foreign at the same time. Greece has never quite stopped looking at cannabis that way: fine to grow, fine to sell somewhere else, but kept at arm's length once it comes home. This is the story of how that instinct shows up again and again, from the Histories to a government gazette published last year.

Herodotus and the Scythian Vapor Bath

Photo by Pembegül Dal via Pexels.

The oldest surviving reference to cannabis in Western writing sits in Book 4 of Herodotus's Histories, composed sometime in the 420s BCE, in a passage describing the funeral customs of the Scythians -- the nomadic peoples who ranged across the steppe north of the Black Sea, well outside the Greek world Herodotus knew firsthand. In sections 4.73 through 4.75, he describes mourners setting up small tents, crawling inside, and throwing hemp seed onto stones that had been heated red-hot in a fire. The result, he writes, produced a vapor-bath so intense that no Greek steam bath could match it, and the Scythians inside would howl with what he clearly reads as pleasure.

2017 on Paper: How Greece Legalized Medical Cannabis

Photo by Nikolay Demirev via Pexels.

Greece's modern legal cannabis framework opens with a single administrative act: a joint ministerial decision in July 2017 that moved cannabis from Table A of the country's controlled substances schedule to Table B, the reclassification that legally separates medical and industrial use from blanket prohibition. That decision didn't create a functioning industry by itself -- it created the possibility of one, and the actual machinery came a year later with Law 4523/2018, which laid out how licensed cultivation, processing, and export of finished medicinal cannabis products would actually work in practice.

The Seven-Year Wait for a Prescription

Photo by National Cancer Institute via Unsplash.

Here's the number that captures the whole paradox in one line: Greece legalized medical cannabis in 2017, and the first Greek patient filled a domestic prescription at a pharmacy on February 19, 2024. Seven years passed between the law existing on paper and the law doing anything for an actual person holding a prescription.

Larissa, Examilia, and Greece's Export Ambitions

Greece's medical cannabis market is projected to grow sharply, rising from $32 million in 2025 to an estimated $46.8 million in 2026—a roughly 46% increase.

The infrastructure that finally closed that seven-year gap is real, and it's scaling faster than the patient-access story suggests. Curity Pharma received its operational cultivation license in March 2025 for a 60,700-square-meter facility in Larissa Industrial Park in central Greece, one of the larger single-site medical cannabis grows anywhere in the EU. Tikun Olam, the Israeli-founded cannabis company with a long track record in cultivar development, built a 56,000-square-meter facility in Examilia near Corinth and shipped its first exports to Switzerland in November 2024 -- a meaningful signal given Switzerland's own tightly regulated medical cannabis import rules.

2026: The CBD Flower Ban

Photo by RDNE Stock project via Pexels.

Just as that export story was gaining momentum, Greece tightened the domestic screws again. In April 2026, the Health Ministry opened public consultation on a draft law meant to update rules governing cannabis, nicotine, and tobacco products together -- an unusual grouping that hinted at how the government was thinking about cannabis: as a consumer product to be managed alongside vaping and smoking, not as a medicine or an agricultural export.

Line up the last decade of Greek cannabis policy and a clear shape emerges: license the farms, court the pharmaceutical exporters, publish the shipment numbers to Germany and Switzerland -- and then, whenever the product threatens to become something an ordinary Greek consumer might buy off a shelf, pull back hard. It happened with the seven-year gap between legalization and an actual filled prescription. It's happening again with a CBD flower ban arriving in the same law that raised the industrial hemp THC threshold to bring Greece in line with the rest of the EU. Cultivation for export keeps getting easier. Retail at home keeps getting harder.

That's not really a policy contradiction so much as a very old reflex. Herodotus wrote about the Scythians with genuine fascination and a Greek's instinct to keep the practice at a comfortable distance -- impressive, foreign, not something civilized people did themselves. Twenty-four centuries later, the same country is building some of the EU's more serious medical cannabis export infrastructure while its own health ministry sends inspectors to clear hemp flower off store shelves.

Whether Greece ends up as the Mediterranean's cultivation and export hub it's clearly angling to become, or stays a case study in how far a country can separate what it grows from what it lets its own citizens buy, probably comes down to one thing: whether Athens can decouple the export ambition from the domestic anxiety. Right now those two impulses are running on separate tracks, and nothing in Law 5302/2026 suggests they're about to merge. Readers with money or a prescription riding on this should check current EOF guidance directly -- this is a regulatory picture that keeps moving, and it hasn't finished moving yet.